Belmont, MA – Oryon Cell Therapies has announced the appointment of Burkhard Blank as Chief Medical Officer. About Oryon Cell Therapies: Oryon Cell Therapies is a clinical-stage biotechnology company headquartered in Belmont, Mass., focused on developing autologous neuron replacement medicines for Parkinsons disease and other neurodegenerative disorders. The company specializes in innovative cell therapies aimed at addressing unmet needs in neurology through advanced neuron replacement approaches. On the specified date, Oryon announced the appointment of Burkhard Blank, M.D., as its Chief Medical Officer, highlighting its commitment to strengthening leadership in clinical development and regulatory strategy. Dr. Blank brings decades of experience, including leading global programs that resulted in eight NDA and MAA approvals, two of which were for Parkinsons disease treatments like Mirapex. This strategic hire underscores Oryons position as an emerging player advancing neuron replacement therapies in the competitive neurodegenerative disease market.

For more information on Oryon Cell Therapies please visit: https://oryoncelltherapies.com/

Oryon Cell Therapies
Address Unavailable
Belmont, MA 2478
Phone:
LinkedIn Page: https://www.linkedin.com/company/oryon-cell-therapies/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved